Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Devices for Inhaled Medications Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Devices for Inhaled Medications Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Dry Powder Inhalers
      • 1.3.3 Metered-Dose Inhalers
      • 1.3.4 Nebulizers
      • 1.3.5 Soft Mist Inhaler
    • 1.4 Market Segment by Application
      • 1.4.1 Global Devices for Inhaled Medications Market Share by Application (2019-2025)
      • 1.4.2 Clinic
      • 1.4.3 Hospital
      • 1.4.4 Home
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Devices for Inhaled Medications Production Value 2014-2025
      • 2.1.2 Global Devices for Inhaled Medications Production 2014-2025
      • 2.1.3 Global Devices for Inhaled Medications Capacity 2014-2025
      • 2.1.4 Global Devices for Inhaled Medications Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Devices for Inhaled Medications Market Size CAGR of Key Regions
      • 2.2.2 Global Devices for Inhaled Medications Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Devices for Inhaled Medications Capacity by Manufacturers
      • 3.1.2 Global Devices for Inhaled Medications Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Devices for Inhaled Medications Revenue by Manufacturers (2014-2019)
      • 3.2.2 Devices for Inhaled Medications Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Devices for Inhaled Medications Market Concentration Ratio (CR5 and HHI)
    • 3.3 Devices for Inhaled Medications Price by Manufacturers
    • 3.4 Key Manufacturers Devices for Inhaled Medications Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Devices for Inhaled Medications Market
    • 3.6 Key Manufacturers Devices for Inhaled Medications Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Dry Powder Inhalers Production and Production Value (2014-2019)
      • 4.1.2 Metered-Dose Inhalers Production and Production Value (2014-2019)
      • 4.1.3 Nebulizers Production and Production Value (2014-2019)
      • 4.1.4 Soft Mist Inhaler Production and Production Value (2014-2019)
    • 4.2 Global Devices for Inhaled Medications Production Market Share by Type
    • 4.3 Global Devices for Inhaled Medications Production Value Market Share by Type
    • 4.4 Devices for Inhaled Medications Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Devices for Inhaled Medications Consumption by Application

    6 Production by Regions

    • 6.1 Global Devices for Inhaled Medications Production (History Data) by Regions 2014-2019
    • 6.2 Global Devices for Inhaled Medications Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Devices for Inhaled Medications Production Growth Rate 2014-2019
      • 6.3.2 United States Devices for Inhaled Medications Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Devices for Inhaled Medications Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Devices for Inhaled Medications Production Growth Rate 2014-2019
      • 6.4.2 European Union Devices for Inhaled Medications Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Devices for Inhaled Medications Import & Export
    • 6.5 China
      • 6.5.1 China Devices for Inhaled Medications Production Growth Rate 2014-2019
      • 6.5.2 China Devices for Inhaled Medications Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Devices for Inhaled Medications Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Devices for Inhaled Medications Consumption by Regions

    • 7.1 Global Devices for Inhaled Medications Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Devices for Inhaled Medications Consumption by Type
      • 7.2.2 United States Devices for Inhaled Medications Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Devices for Inhaled Medications Consumption by Type
      • 7.3.2 European Union Devices for Inhaled Medications Consumption by Application
    • 7.4 China
      • 7.4.1 China Devices for Inhaled Medications Consumption by Type
      • 7.4.2 China Devices for Inhaled Medications Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Devices for Inhaled Medications Consumption by Type
      • 7.5.2 Rest of World Devices for Inhaled Medications Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Consort Medical
      • 8.1.1 Consort Medical Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Devices for Inhaled Medications
      • 8.1.4 Devices for Inhaled Medications Product Introduction
      • 8.1.5 Consort Medical Recent Development
    • 8.2 Inhalexper
      • 8.2.1 Inhalexper Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Devices for Inhaled Medications
      • 8.2.4 Devices for Inhaled Medications Product Introduction
      • 8.2.5 Inhalexper Recent Development
    • 8.3 Cambridge Consultants
      • 8.3.1 Cambridge Consultants Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Devices for Inhaled Medications
      • 8.3.4 Devices for Inhaled Medications Product Introduction
      • 8.3.5 Cambridge Consultants Recent Development
    • 8.4 Hovione
      • 8.4.1 Hovione Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Devices for Inhaled Medications
      • 8.4.4 Devices for Inhaled Medications Product Introduction
      • 8.4.5 Hovione Recent Development
    • 8.5 Catalent, Inc
      • 8.5.1 Catalent, Inc Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Devices for Inhaled Medications
      • 8.5.4 Devices for Inhaled Medications Product Introduction
      • 8.5.5 Catalent, Inc Recent Development
    • 8.6 VertMarkets, Inc
      • 8.6.1 VertMarkets, Inc Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Devices for Inhaled Medications
      • 8.6.4 Devices for Inhaled Medications Product Introduction
      • 8.6.5 VertMarkets, Inc Recent Development
    • 8.7 Qualicaps
      • 8.7.1 Qualicaps Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Devices for Inhaled Medications
      • 8.7.4 Devices for Inhaled Medications Product Introduction
      • 8.7.5 Qualicaps Recent Development
    • 8.8 3M
      • 8.8.1 3M Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Devices for Inhaled Medications
      • 8.8.4 Devices for Inhaled Medications Product Introduction
      • 8.8.5 3M Recent Development
    • 8.9 Aerovance
      • 8.9.1 Aerovance Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Devices for Inhaled Medications
      • 8.9.4 Devices for Inhaled Medications Product Introduction
      • 8.9.5 Aerovance Recent Development
    • 8.10 AstraZeneca
      • 8.10.1 AstraZeneca Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Devices for Inhaled Medications
      • 8.10.4 Devices for Inhaled Medications Product Introduction
      • 8.10.5 AstraZeneca Recent Development
    • 8.11 Boehringer Ingelheim
    • 8.12 Chiesi
    • 8.13 Cipla
    • 8.14 Civitas/Alkermes
    • 8.15 GlaxoSmithKline
    • 8.16 Hovione
    • 8.17 Mannkind
    • 8.18 Mantecorp
    • 8.19 Meda
    • 8.20 MicroDose Therapeutx
    • 8.21 Novartis

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Devices for Inhaled Medications Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Devices for Inhaled Medications Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Devices for Inhaled Medications Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Devices for Inhaled Medications Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Devices for Inhaled Medications Production Forecast by Type
      • 9.7.2 Global Devices for Inhaled Medications Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Devices for Inhaled Medications Sales Channels
      • 10.2.2 Devices for Inhaled Medications Distributors
    • 10.3 Devices for Inhaled Medications Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      In 2019, the market size of Devices for Inhaled Medications is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Devices for Inhaled Medications.

      This report studies the global market size of Devices for Inhaled Medications, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Devices for Inhaled Medications production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Consort Medical
      Inhalexper
      Cambridge Consultants
      Hovione
      Catalent, Inc
      VertMarkets, Inc
      Qualicaps
      3M
      Aerovance
      AstraZeneca
      Boehringer Ingelheim
      Chiesi
      Cipla
      Civitas/Alkermes
      GlaxoSmithKline
      Hovione
      Mannkind
      Mantecorp
      Meda
      MicroDose Therapeutx
      Novartis

      Market Segment by Product Type
      Dry Powder Inhalers
      Metered-Dose Inhalers
      Nebulizers
      Soft Mist Inhaler

      Market Segment by Application
      Clinic
      Hospital
      Home

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Devices for Inhaled Medications status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Devices for Inhaled Medications manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Devices for Inhaled Medications are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now